Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren
Skc4.0
Skullcap – Forschung
Überwiegend Mechanismus / Beobachtung
69 begutachtete Studien
Was die Evidenz sagt
Überwiegend Mechanismus / Beobachtung
Die meisten Studien zu Skullcap sind mechanistisch oder beobachtend statt RCTs, die einen klinischen Effekt messen — betrachte die Ergebnisse als vorläufig.
Die meiste Evidenz stammt aus hochwertigen randomisierten Studien, veröffentlicht 2003–2026 mit einer typischen Studiengröße von 59 Teilnehmenden.
Basierend auf 68 Studien · 10 RCTs · 423 Teilnehmende insgesamt
Konfidenz
Mittlere Konfidenz
Was die Studien gefunden haben
1geholfen· 67 weitere ohne bewertete Effektdaten
Nach Outcome
Therapeutic & clinical
Überwiegend Mechanismus / Beobachtung26 Studien
Inflammation
Überwiegend Mechanismus / Beobachtung10 Studien
Safety profile
Überwiegend Mechanismus / Beobachtung9 Studien
Neuroprotection & brain aging
Überwiegend Mechanismus / Beobachtung6 Studien
Cognitive function
Überwiegend Mechanismus / Beobachtung6 Studien
Anxiety & stressReduzierte nervöse Anspannung und Angst · 30-60 Minuten akut; 2-4 Wochen kumulativ · Beruhigung der Stressreaktion und nervösen Anspannung · 1-3 Wochen
1Cardiac health restoration following myocardial ischemia-reperfusion injurySystematische ÜbersichtCited 3×2025
Research in both animal and cell models suggests that these flavonoids, especially baicalin, can restore cardiac health following MIRI, improving cardiac performance, and reducing cardiac damage.
Nasiri R et al. · Tissue & cell (2025)
Research in both animal and cell models suggests that these flavonoids, especially baicalin, can restore cardiac health following MIRI, improving cardiac performance, and reducing cardiac damage.
These findings underscore the potential of baicalin and baicalein as therapeutic options for MIRI.
However, further research and clinical trials are necessary to elucidate their mechanisms fully and to develop baicalin into a viable treatment.
2Pharmacological activity of baicaleinSystematische ÜbersichtCited 23×2023
In this review, we summarized the latest reports on one of the most important aglycones with respect to the pharmacological activity and high content in Baikal skullcap, which is 5,6,7-trihydroxyflavone (baicalein).
Chmiel M et al. · International journal of molecular sciences (2023)
It has been documented that the extract of Baikal skullcap (Scutellaria baicalensis) has hepatoprotective, calming, antiallergic, and anti-inflammatory properties.
Flavonoid compounds found in the extract, including baicalein, have strong antiradical activity, which improves overall health and increases feelings of well-being.
Plant-derived bioactive compounds with antioxidant activity have for a long time been used as an alternative source of medicines to treat oxidative stress-related diseases.
This review will encourage researchers to generalize the merits of wogonin to be used as potential compound for cancer treatment.
Tuli HS et al. · Experimental biology and medicine (Maywood, N.J.) (2023)
This review focuses on a complete overview of published reports that suggest chemopreventive action of wogonin and the mechanistic insights behind these neoplastic activities.
It also emphasizes the synergistic improvements made by wogonin in chemoprevention.
The factual data in this mini-review stimulate additional research on chemistry and toxicological profile of wogonin to confirm its safety issues.
4Cancer prevention and treatment efficacySystematische ÜbersichtCited 112×2022
These studies propound the use of WOG as a potential anticancer candidate; however, further high-quality studies are required to firmly establish the clinical efficacy of WOG for the prevention and treatment of human malignancies.
Banik K et al. · Phytotherapy research : PTR (2022)
WOG, in combination with established chemotherapeutic drugs, improves the efficacy of treatment and lowers toxicity.
Nevertheless, human trials are warranted to validate these findings.
Numerous preclinical studies, combined with an extensive margin of safety and no severe side effects, underscore WOG's therapeutic potential as an anticancer drug.
Flavocoxid may therefore provide a potential therapeutic approach to the treatment of chronic inflammatory conditions.
Bitto A et al. · Mediators of inflammation (2014)
Flavocoxid is a mixed extract containing baicalin and catechin and it acts as a dual balanced inhibitor of cyclooxygenase-1 (COX-1) and COX-2 peroxidase enzyme activities with a significant inhibition of 5-lipoxygenase (5-LOX) enzyme activity in vitro.
Flavocoxid downregulates gene or protein expression of several inflammatory markers and exerts also strong antioxidant activity in several experimental models.
Controlled clinical trials and a postmarketing study have clearly shown that flavocoxid is as effective as naproxen in managing the signs and symptoms of osteoarthritis of the knee and it has better upper gastrointestinal, renal, and respiratory safety profile than naproxen.
8Neuroprotection against ischemia-induced neurodegenerationÜbersicht2021
It is with hope that the therapeutic potential of these flavonoids can be utilized and developed as natural treatments for ischemia-induced injuries of the central nervous system (CNS).
Pan L et al. · Oxidative medicine and cellular longevity (2021)
They have been demonstrated to exert promising pharmacological capabilities in preventing cell and tissue damage.
This review focuses on the therapeutic potentials of these flavonoids against ischemia-induced neurotoxicity and damage in the brain and retina.
The bioactivity and bioavailability of baicalein, baicalin, and wogonin are also discussed.
While questions remain in the literature regarding the medicinal value of these supplements in treating mood and anxiety disorders, based on cellular and animal studies as well as human clinical trials the literature supports a role for these preparations as useful alternatives in the management of the stress and anxiety of everyday life.
Weeks BS · Medical science monitor : international medical journal of experimental and clinical research (2009)
Further, extracts of Magnolia and Phellondendron bark are mild sedatives.
Supplements such as gamma-aminobutyric acid (GABA), theanine, tryptophan and 5-hydroxytryptophan (5-HTP) are reported to promote relaxation.
In general, these supplements appear to act as GABA receptor agonists or to boost GABA levels, although Kava inhibits both norephinephrine uptake and sodium and potassium channels and 5-HTP may act through elevation of serotonin.
13CrossoverCited 1×n=43 · small study2025
The herbal supplement is safe and enhances mood, reduces subjective anxiety, and improves cognition under stress, though cognitive effects are variable without stress exposure.The study was registered on clinicaltrials.gov (identifier: NCT05757050).
Dodd F et al. · Journal of psychopharmacology (Oxford, England) (2025)
A higher proportion of subjects experienced ⩾30% gains in social satisfaction scores after 7 days.
The herbal supplement is safe and enhances mood, reduces subjective anxiety, and improves cognition under stress, though cognitive effects are variable without stress exposure.The study was registered on clinicaltrials.gov (identifier: NCT05757050).
Wolfson P, Hoffmann DL · Altern Ther Health Med (2003)
19Total Mood DisturbanceCrossoverCited 18×n=43 · small study2014
However, as S. lateriflora significantly enhanced global mood without a reduction in energy or cognition, further study assessing its putative anxiolytic effects in notably anxious subjects with co-morbid depression is warranted.
Brock C et al. · Phytotherapy research : PTR (2014)
Likely real
In this relatively non-anxious population (81% were mildly anxious or less, i.e.
However, there was a significant group effect (p = 0.049), suggesting a carryover effect of skullcap.
For Total Mood Disturbance measured by the Profile of Mood States, there was a highly significant (p = <0.001) decrease from pre-test scores with skullcap but not placebo (p = 0.072).
This paper reviews recent studies on the mechanism of action and clinical trials of HQ in treating UC based on relevant literature, with the aim of providing valuable insights into future treatment approaches.
Ding Y, Wang CY, Pan YT, Wang YJ, Zhao AG, Wen HZ. · World journal of gastroenterology (2026)
Therefore, there is an urgent need to develop safer and more effective treatment strategies to address the limitations of existing therapies.
Scutellaria baicalensis Georgi (HQ), a traditional Chinese medicinal herb, has been employed in the treatment of UC for over 2000 years.
Recent studies have demonstrated that HQ contains multiple active components capable of treating UC through anti-inflammation, immune modulation, intestinal barrier protection, antioxidant activity, and regulation of the gut microbiota.